Continuous Versus Interrupted Abdominal Wall Closure After Emergency Midline Laparotomy

NCT ID: NCT00544583

Last Updated: 2010-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2/PHASE3

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-11-30

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients undergoing primary midline laparotomy for an emergency surgical intervention with a suspected septic focus in the abdominal cavity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

More than 700.000 open abdominal surgeries (laparotomies) are performed each year in Germany (2). A major surgical complication after laparotomy is abdominal fascia dehiscence which might appear either as early (burst abdomen with evisceration) or as late complication (incisional hernia). These patients usually undergo surgery for secondary fascial closure associated with markedly increased morbidity (3) including high recurrence rates (up to 45%) (4). The applied surgical strategy of abdominal wall closure (i.e. the combination of suture technique and material) is of high relevance for prevention of fascia dehiscence and, moreover, constitutes the main factor directly controllable by the surgeon. While several randomized controlled trials (RCT) (3; 5-8) as well as meta-analyses (9-12) exist that address the issue of optimal fascia closure in elective laparotomies, there is no RCT dealing exclusively with the emergency setting. As a result abdominal fascia closure is performed according to the surgeon's individual preference rather than according to evidence-based data. Therefore, the present RCT is designed to compare the most established strategies (continuous slowly absorbable sutures and interrupted rapidly absorbable sutures) for abdominal wall closure in order to determine differences between both strategies after midline incisions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laparotomy Hernia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Interrupted closure with Vicryl equivalent sutures (USP 2, 45 cm)

Group Type ACTIVE_COMPARATOR

Interrupted sutures

Intervention Type PROCEDURE

Interrupted sutures for abdominal fascia closure with Vicryl equivalent sutures (USP 2, 45 cm)

B

Continuous closure with PDS II equivalent sutures (USP 1, 150 cm loops)

Group Type EXPERIMENTAL

Continuous sutures

Intervention Type PROCEDURE

Continuous sutures for abdominal fascia closure with PDS II equivalent USP 1, 150 cm loops

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interrupted sutures

Interrupted sutures for abdominal fascia closure with Vicryl equivalent sutures (USP 2, 45 cm)

Intervention Type PROCEDURE

Continuous sutures

Continuous sutures for abdominal fascia closure with PDS II equivalent USP 1, 150 cm loops

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age equal or greater than 18 years
* Expected survival time more than 12 months
* Patients undergoing primary and emergency midline laparotomy (patients with prior laparoscopy (not colon resections) or minor abdominal operation (e.g. appendectomy, cholecystectomy, hysterectomy, sectio) may be included into the trial)
* Suspected septic abdominal focus (e.g. perforated stomach ulcer, perforated diverticulitis)
* Informed consent

* Successful source control
* Abdominal lavage

Exclusion Criteria

* Participation in another intervention-trial with interference of intervention and outcome of this study

* Planned re-laparotomy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Heidelberg University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of General, Visceral and Transplantation Surgery

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nuh N Rahbari, MD

Role: STUDY_DIRECTOR

Department of Surgery, University of Heidelberg

Markus W Büchler, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Surgery, University of Heidelberg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Surgery

Heidelberg, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nuh N Rahbari, MD

Role: CONTACT

+49 6221 56 39448

Sabine - Voß, MD

Role: CONTACT

+49 6221 56 6986

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nuh N Rahbari, MD

Role: primary

+ 49 6221 56 39448

SDGC Heidelberg

Role: backup

+49 6221 56 6986

References

Explore related publications, articles, or registry entries linked to this study.

Rahbari NN, Knebel P, Kieser M, Bruckner T, Bartsch DK, Friess H, Mihaljevic AL, Stern J, Diener MK, Voss S, Rossion I, Buchler MW, Seiler CM. Design and current status of CONTINT: continuous versus interrupted abdominal wall closure after emergency midline laparotomy - a randomized controlled multicenter trial [NCT00544583]. Trials. 2012 May 30;13:72. doi: 10.1186/1745-6215-13-72.

Reference Type DERIVED
PMID: 22647387 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S206/2007

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.